Dr. Edmond Bedrossian is a San Francisco, California based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 450 Sutter St, Suite 2439, San Francisco. Patients can reach him at 415-956-6610.
Dr. Edmond Bedrossian deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Edmond Bedrossian speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Edmond Bedrossian
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DDS
Accepts Medicare Assignment:
May Accept
Practice Address:
450 Sutter St, Suite 2439, San Francisco, California, 94108-4206
Phone:
415-956-6610
Fax:
415-956-6618
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
5991066094
Enrollment ID:
I20180307000418
NPI Number:
1508988106
NPI Enumeration Date:
04 Apr, 2007
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
450 Sutter St, Suite 2439 San Francisco, California
Zip:
94108-4206
Phone Number:
415-956-6610
Fax Number:
415-956-6618
Patients can reach Dr. Edmond Bedrossian at 450 Sutter St, Suite 2439, San Francisco, California or can call to book an appointment on 415-956-6610. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.